BIOXCEL THERAPEUTICS INC's ticker is BTAI and the CUSIP is 09075P105. A total of 109 filers reported holding BIOXCEL THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is 0.30 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,094,149 | -73.1% | 432,470 | +98.4% | 0.00% | -75.0% |
| Q1 2023 | $4,067,712 | +508.9% | 217,991 | +285.9% | 0.01% | +500.0% |
| Q3 2022 | $668,000 | -63.9% | 56,493 | -59.7% | 0.00% | -66.7% |
| Q2 2022 | $1,852,000 | +11.4% | 140,278 | +76.5% | 0.01% | +20.0% |
| Q1 2022 | $1,662,000 | +148.8% | 79,474 | +141.9% | 0.01% | +400.0% |
| Q4 2021 | $668,000 | -57.0% | 32,852 | -35.9% | 0.00% | -66.7% |
| Q3 2021 | $1,555,000 | -59.1% | 51,221 | -60.9% | 0.00% | -66.7% |
| Q2 2021 | $3,806,000 | -40.9% | 130,957 | -12.3% | 0.01% | -47.1% |
| Q1 2021 | $6,445,000 | +763.9% | 149,326 | +768.2% | 0.02% | +466.7% |
| Q3 2020 | $746,000 | -79.3% | 17,200 | -74.7% | 0.00% | -83.3% |
| Q2 2020 | $3,605,000 | – | 68,002 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| APIS CAPITAL ADVISORS, LLC | 40,000 | $836,000 | 1.01% |
| ACT CAPITAL MANAGEMENT, LLC | 20,000 | $418,000 | 0.44% |
| Knoll Capital Management, LLC | 20,000 | $418,000 | 0.26% |
| Artemis Investment Management LLP | 1,428,228 | $29,855,000 | 0.24% |
| Rubric Capital Management LP | 268,528 | $5,615,000 | 0.20% |
| Virtus ETF Advisers LLC | 7,713 | $161,000 | 0.07% |
| BOOTHBAY FUND MANAGEMENT, LLC | 107,700 | $2,252,000 | 0.05% |
| PDT Partners, LLC | 28,031 | $586,000 | 0.05% |
| AllSquare Wealth Management LLC | 3,162 | $66,000 | 0.04% |
| Hennion & Walsh Asset Management, Inc. | 35,221 | $736,000 | 0.04% |